世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
60期
158-159
,共2页
视网膜中央静脉阻塞%诊断%治疗%病例报告
視網膜中央靜脈阻塞%診斷%治療%病例報告
시망막중앙정맥조새%진단%치료%병례보고
Central retinal vein occlusion%Diagnosis%Treatment%Case report
目的：总结双眼视网膜中央静脉阻塞（central retina vein occlusion，CRVO）的特征，供同道借鉴。方法通过临床发现的视网膜中央静脉阻塞（central retina vein occlusion，CRVO）一例罕见疾病，分析发病原因、特征、病情、及治疗方法。结果视网膜静脉阻塞（retina vein occlusion，RVO）是目前仅次于糖尿病视网膜病变的视网膜血管性疾病，易引起视力下降。黄斑水肿是RVO引起视力下降的最主要的原因。现阶段治疗黄斑水肿的比较热门有效的是球内注射阿瓦斯丁（Avastin）、球内注射雷珠单抗（Lucentis，LU）、贝伐单抗（Bevacizumab,BE）和光动力疗法（PDT）。球内注射雷珠单抗、贝伐单抗和光动力疗法比较昂贵，球内注射阿瓦斯丁相对便宜，在滇西地区应用较多,该患者在治疗期间双眼均注射阿瓦斯丁。患者左眼治疗耽误最佳时期，视力恢复差，右眼治疗及时，视力恢复较好。结论视网膜静脉阻塞的不同类型预后差别很大，双眼CRVO的病人不多见，治疗复杂，要防止复发,进行密切随访。
目的：總結雙眼視網膜中央靜脈阻塞（central retina vein occlusion，CRVO）的特徵，供同道藉鑒。方法通過臨床髮現的視網膜中央靜脈阻塞（central retina vein occlusion，CRVO）一例罕見疾病，分析髮病原因、特徵、病情、及治療方法。結果視網膜靜脈阻塞（retina vein occlusion，RVO）是目前僅次于糖尿病視網膜病變的視網膜血管性疾病，易引起視力下降。黃斑水腫是RVO引起視力下降的最主要的原因。現階段治療黃斑水腫的比較熱門有效的是毬內註射阿瓦斯丁（Avastin）、毬內註射雷珠單抗（Lucentis，LU）、貝伐單抗（Bevacizumab,BE）和光動力療法（PDT）。毬內註射雷珠單抗、貝伐單抗和光動力療法比較昂貴，毬內註射阿瓦斯丁相對便宜，在滇西地區應用較多,該患者在治療期間雙眼均註射阿瓦斯丁。患者左眼治療耽誤最佳時期，視力恢複差，右眼治療及時，視力恢複較好。結論視網膜靜脈阻塞的不同類型預後差彆很大，雙眼CRVO的病人不多見，治療複雜，要防止複髮,進行密切隨訪。
목적：총결쌍안시망막중앙정맥조새（central retina vein occlusion，CRVO）적특정，공동도차감。방법통과림상발현적시망막중앙정맥조새（central retina vein occlusion，CRVO）일례한견질병，분석발병원인、특정、병정、급치료방법。결과시망막정맥조새（retina vein occlusion，RVO）시목전부차우당뇨병시망막병변적시망막혈관성질병，역인기시력하강。황반수종시RVO인기시력하강적최주요적원인。현계단치료황반수종적비교열문유효적시구내주사아와사정（Avastin）、구내주사뢰주단항（Lucentis，LU）、패벌단항（Bevacizumab,BE）화광동력요법（PDT）。구내주사뢰주단항、패벌단항화광동력요법비교앙귀，구내주사아와사정상대편의，재전서지구응용교다,해환자재치료기간쌍안균주사아와사정。환자좌안치료탐오최가시기，시력회복차，우안치료급시，시력회복교호。결론시망막정맥조새적불동류형예후차별흔대，쌍안CRVO적병인불다견，치료복잡，요방지복발,진행밀절수방。
Objective:Summarize the characteristics of eyes with central retinal vein occlusion(CRVO), reference for the fellow. Methods: A rare disease of central retinal vein occlusion was found in the clinic, and the cause, characteristics, and treatment of the disease were analyzed.Results: Retinal vein occlusion (RVO) is retinal vascular disease which only after diabetic retinopathy currently,can lead to decreased vision easily . Macular edema is the main cause of visual acuity decrease in RVO. At this stage in the treatment of macular edema is popular and effective as Avastin injection, intravitreal injection of thunder natalizumab(Lucentis, LU), bevacizumab(BE), and photodynamic therapy(PDT).Intravitreal injection of thunder natalizumab, bevacizumab and photodynamic therapy is more expensive,and intravitreal injection of Avastin is relatively cheap.There is widely used Avastin in western Yunnan. the patient eyes were injected Avastin during treatment.The left eye was delayed for the best period, the poor eyesight recovered, the right eye was treated in time,Good vision recovery.Conclusion: The prognosis of different types of retinal vein occlusion is very different.The patients with CRVO are rare and the treatment is complex.To prevent recurrence, close follow-up is necessary.
